First Trust NYSE Arca Biotechnology Index Fund·Financial Services

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT - Get Free Report) was the recipient of a large growth in short interest in February. As of February 13th, there was short interest totaling 31,210 shares, a growth of 29.5% from the January 29th total of 24,107 shares. Approximately 3.0% of the shares of the stock

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
The First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index.
Financial Services
Asset Management
2006-06-23
0.85
Market Peers





